Table 1.
The demographic and clinicopathologic characteristics of newly diagnosed ALL patients (25 patients)
|
| |
|---|---|
| Clinical factor | Numbers/Percentage |
|
| |
| Male | 17 (68.0) |
| Female | 8 (32.0) |
| Median age (Y) | 28 (6-30) |
| BM blast | 81 (20-95) |
| Median WBC (106/μl) | 19000 (700-400000) |
| Immunophenotype B-ALL | 15 (60.0) |
| CD19+median | 69.8 |
| CD20+median | 11.2 |
| CD22+median | 42.8 |
| Cyto CD 79α | 63.8 |
| CD34+median | 42.8 |
| TdT+median | 51.5 |
| Immunophenotype T-ALL | 10 (40.0) |
| CD2+median | 96.1 |
| CD3+median | 75.9 |
| CD5+median | 85.1 |
| CD7+median | 88.5 |
| CD34+median | 60.4 |
| TdT+median | 53.0 |
|
| |
Data are presented as n (%) or %. BM; Bone Marrow, WBC; White blood cell, B-ALL; B-cell acute lymphoblastic leukemia, and T-ALL; T-cell acute lymphoblastic leukemia.